Roivant Sciences Ltd. (ROIV) Financials

ROIV Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 7.3 billion 728.1 million
2023-09-30 2.1 billion 739.9 million
2023-06-30 2.1 billion 802.5 million
2023-03-31 2.4 billion 782.0 million

ROIV Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -210.8 million 54.3 million
2023-09-30 -196.7 million 49.3 million
2023-06-30 -250.3 million 49.3 million
2023-03-31 -180.7 million 25.3 million

ROIV Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 5.1 billion
2023-09-30 -331.1 million
2023-06-30 -327.8 million
2023-03-31 -60.9 million

ROIV Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 6.7 billion - 57.5 million
2023-09-30 1.4 billion - 59.5 million
2023-06-30 1.4 billion 385.1 million 63.2 million
2023-03-31 1.7 billion 375.5 million 65.2 million

ROIV Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 844.5 million
2023-09-30 770.2 million
2023-06-30 759.3 million
2023-03-31 742.5 million

ROIV Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 355000 123.7 million 197.3 million -
2023-09-30 275000 132.0 million 164.4 million -
2023-06-30 403000 125.1 million 156.2 million 156.2 million
2023-03-31 1.6 million 131.9 million 125.5 million -

ROIV Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 37.1 million 3.7 million
2023-09-30 37.1 million 3.3 million
2023-06-30 21.6 million 4.2 million
2023-03-31 27.4 million 4.2 million

ROIV

Price: $11.03

52 week price:
7.01
13.24

Earnings Per Share: 5.27 USD

P/E Ratio: -7.35

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 1.4 million

Market Capitalization: 9.2 billion

Links: